Florida sues Pfizer and Albert Bourla over COVID-19 vaccine marketing
Florida Attorney General James Uthmeier brought a civil case against Pfizer and its chief executive, Albert Bourla, in St. Lucie County. Florida alleges the company misled consumers about the COVID-19 vaccine's safety and its effect on virus transmission, including by withholding risk information. The state is pursuing monetary sanctions, recovery of alleged gains and court restrictions; Pfizer called the accusations unfounded and said it will respond.
Why it matters
The suit creates a new state-level legal and reputational issue for Pfizer. The case remains at an early stage, and Pfizer says its vaccine communications were supported by science and that it stands behind the product's safety and effectiveness.
Key facts
- 1James Uthmeier filed the civil action against Pfizer and Albert Bourla in the 19th Judicial Circuit Court in St. Lucie County. en.cibercuba.com
- 2Florida bases its claims on the Florida Deceptive and Unfair Trade Practices Act. en.cibercuba.com
- 3Florida is asking for penalties of more than $50,000 for each violation, repayment of alleged profits and an order barring future violations. en.cibercuba.com
- 4Pfizer says the FDA first authorized its COVID-19 vaccine in December 2020. cubaheadlines.com
- 5A Florida grand jury said in January 2025 that it found no evidence vaccine makers had breached state or federal law. cubaheadlines.com
- 6The third material describes the complaint as 49-page. naturalnews.com
Open questions
- The materials differ on the requested penalties: materials 1 and 2 say more than $50,000 for each violation, while material 3 says $10,000 per violation and $15,000 for violations involving an elderly or disabled person.
- Material 3 says the lawsuit was filed on Thursday, Oct.1, while the other materials do not provide a filing date.
- The allegations have not been adjudicated, and Pfizer denies them.
Summary written by AlphAI from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.